Description：

GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase 2.

Chemical Information：

Molecular Weight (MW)		456.56
Formula		C23H28N4O4S
CAS No.		1032823-75-8
Solubility (25°C) *	DMSO	34 mg/mL (74.46 mM)
	Water	Insoluble
	Alcohol	Insoluble

Preparing Stock Solutions

Concentration Volume (DMSO) Mass	1 mg	5 mg	10 mg
1 mM	2.1903 mL	10.9515 mL	21.9029 mL
5 mM	0.4381 mL	2.1903 mL	4.3806 mL
10 mM	0.2190 mL	1.0951 mL	2.1903 mL
50 mM	0.0438 mL	0.2190 mL	0.4381 mL

Bought notes(bought amounts latest0)

No one bought this product

Total 0 records, divided into1 pages. First Prev Next Last